Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2

Journal of Viral Hepatitis

Volumn 22, Issue s1, 2015, Pages 6-25

  Saraswat, V ^a   Norris, S ^b   De Knegt, R J ^c   Sanchez Avila, J F ^d   Sonderup, M ^e   Zuckerman, E ^f   Arkkila, P ^g   Stedman, C ^h   Acharya, S ⁱ   Aho, I ^g   Anand, A C ^j   Andersson, M I ^k   Arendt, V ^l   Baatarkhuu, O ⁿ   Barclay, K ^o   Ben Ari, Z ^p   Bergin, C ^b,q   Bessone, F ^r   Blach, S ^s   Blokhina, N ^t   Brunton, C R ^u   Choudhuri, G ^v   Chulanov, V ^w   Cisneros, L ^x   Croes, E A ^y   Dahgwahdorj, Y A ⁿ   Dalgard, O ^z   Daruich, J R ^aa   Dashdorj, N R ^ab   Davaadorj, D ⁿ   De Vree, M ^ac   Estes, C ^s   Flisiak, R ^ad   Gadano, A C ^ae   Gane, E ^af   Halota, W ^ag   Hatzakis, A ^ah   Henderson, C ^ai   Hoffmann, P ^aj   Hornell, J ^o   Houlihan, D ^ak   Hrusovsky, S ^al,am   Jarcuska P ^an   Kershenobich, D ^d   Kostrzewska, K ^ao   Kristian, P ^an   Leshno, M ^p   Lurie, Y ^ap   Mahomed, A ^aq   Mamonova, N ^ar   Mendez Sanchez, N ^as   Mossong, J ^at   Nurmukhametova, E ^t   Nymadawa, P ^au   Oltman, M ^av   Oyunbileg, J ^aw   Oyunsuren, Ts ^ax   Papatheodoridis, G ^ah   Pimenov, N ^w   Prabdial Sing, N ^ay,az   Prins, M ^ba,bb   Puri, P ^bc   Radke, S ^bd,be   Rakhmanova, A ^bf   Razavi, H ^s   Razavi Shearer, K ^s   Reesink, H W ^bb   Ridruejo, E ^bg   Safadi, R ^bh   Sagalova, O ^bi   Sanduijav, R ^aw   Schreter I ^an   Seguin Devaux, C ^m   Shah, S R ^bj   Shestakova, I ^bk,bl   Shevaldin, A ^ag   Shibolet, O ^p,bm   Sokolov, S ^bn   Souliotis, K ^bo   Spearman, C W ^bp   Staub, T ^l   Strebkova, E A ^bq   Struck, D ^m   Tomasiewicz, K ^br   Undram, L ⁿ   Van Der Meer, A J ^c   Van Santen, D ^bs   Veldhuijzen, I ^bt   Villamil, F G ^bu   Willemse, S ^bb   Zuure, F R ^bs   Silva, M O ^bs   Sypsa, V ^ah   Gower, E ^s   more..

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b ST JAMES S HOSPITAL   (Ireland)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^g HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^h UNIVERSITY OF OTAGO   (New Zealand)

ⁱ ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^j INDRAPRASTHA APOLLO HOSPITAL   (India)

^k UNIVERSITY OF STELLENBOSCH   (South Africa)

^l CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^m LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

ⁿ MONGOLIAN NATIONAL UNIVERSITY OF MEDICAL SCIENCES   (Mongolia)

^o The Hepatitis Foundation of New Zealand   (New Zealand)

^p TEL AVIV UNIVERSITY   (Israel)

^q TRINITY COLLEGE DUBLIN   (Ireland)

^r UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^s Center for Disease Analysis   (United States)

^t Infectious Diseases Hospital   (Russian Federation)

^u CANTERBURY DISTRICT HEALTH BOARD   (New Zealand)

^v Fortis Memorial Research Institute   (India)

^w CENTRAL RESEARCH INSTITUTE OF EPIDEMIOLOGY   (Russian Federation)

^x INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^y NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^z AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^aa HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^ab Onom Foundation   (Mongolia)

^ac UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^ad MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^ae HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^af AUCKLAND CITY HOSPITAL   (New Zealand)

^ag Department of Infectious Diseases and Hepatology Medical University of Bialystok ^*  (Russian Federation)

^ah UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^ai Needle Exchange Programme New Zealand   (New Zealand)

^aj Directorate of Health   (Luxembourg)

^ak ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^al SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^am 1st Department of Internal Medicine   (Slovakia)

^an P J AFÁRIK UNIVERSITY   (Slovakia)

^ao HTA CONSULTING   (Poland)

^ap SHAARE ZEDEK MEDICAL CENTER   (Israel)

^aq UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^ar Research and Diagnostic Center for Clinical Psychiatry   (Russian Federation)

^as LIVER RESEARCH UNIT   (Mexico)

^at LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

^au Mongolian Academy of Medical Sciences   (Mongolia)

^av Gastroenterology and Hepatology Center   (Slovakia)

^aw National Center for Communicable Diseases   (Mongolia)

^ax INSTITUTE OF CHEMISTRY AND CHEMICAL TECHNOLOGY   (Mongolia)

^ay NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^az UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^ba DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^bb ACADEMIC MEDICAL CENTER   (Netherlands)

^bc ARMY HOSPITAL RESEARCH AND REFERRAL   (India)

^bd INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^be UNIVERSITY OF AUCKLAND   (New Zealand)

^bf St Petersburg AIDS Center   (Russian Federation)

^bg CEMIC   (Argentina)

^bh HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^bi SOUTH URAL STATE MEDICAL UNIVERSITY   (Russian Federation)

^bj Global Hospital   (India)

^bk A I EVDOKIMOV MOSCOW STATE UNIVERSITY OF MEDICINE AND DENTISTRY   (Russian Federation)

^bl N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

^bm TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^bn Tyumen Regional State Autonomous Healthcare Institution Consulting and Diagnostic Centre   (Russian Federation)

^bo UNIVERSITY OF PELOPONNESE   (Greece)

^bp UNIVERSITY OF CAPE TOWN   (South Africa)

^bq SAMARA STATE MEDICAL UNIVERSITY   (Russian Federation)

^br MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^bs UNIVERSIDAD AUSTRAL   (Argentina)

^bt Public Health Service Rotterdam Rijnmond   (Netherlands)

^bu HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

more..

Author keywords

diagnosis; disease burden; epidemiology; HCV; hepatitis C; incidence; mortality; prevalence; treatment

Indexed keywords

ARTICLE; EPIDEMIC; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HISTORY; HUMAN; INDIA; INFECTION RATE; INTRAVENOUS DRUG ABUSE; MORBIDITY; MORTALITY; NETHERLANDS; NONHUMAN; PREVALENCE; RUSSIAN FEDERATION; SYSTEMATIC REVIEW; VIREMIA; ADOLESCENT; ADULT; AGED; CHILD; DRUG UTILIZATION; FEMALE; HEALTH; HEPATITIS C, CHRONIC; INFANT; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

ANTIVIRUS AGENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; FEMALE; GLOBAL HEALTH; HEPATITIS C, CHRONIC; HUMANS; INFANT; INFANT, NEWBORN; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84920274258     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12350     Document Type: Article

References (121)

1. Lozano R, Naghavi M, Foreman K, et al,. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-2128.
2. Wedemeyer H, Duberg AS, Buti M, et al,. Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat 2014; 21 (Suppl 1): 60-89.
3. Deuffic-Burban S, Deltenre P, Buti M, et al,. Predicted effects of treatment for HCV infection vary among European countries. Gastroenterology 2012; 143: 974-985.
4. Razavi H, Waked I, Sarrazin C, et al,. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat 2014; 21 (Suppl 1): 34-59.
5. World Health Organization. Global policy report on the prevention and control of viral hepatitis. January 2013. Available at: http://apps.who.int/iris/bitstream/10665/85397/1/9789241564632-eng.pdf (accessed 14 March 2014).
6. World Health Organization. World health assembly adopts resolution on hepatitis. May 24, 2014. Available at: http://apps.who.int/gb/ebwha/pdf-files/WHA67/A67-R6-en.pdf (accessed 4 June 2014).
7. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST,. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57: 1333-1342.
8. Lavanchy D,. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011; 17: 107-115.
9. Hope VD, Eramova I, Capurro D, Donoghoe MC,. Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association. Epidemiol Infect 2013; 2: 270-86.
10. Cornberg M, Razavi HA, Alberti A, et al,. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int 2011; 31 (Suppl 2): 30-60.
11. Sievert W, Altraif I, Razavi HA, et al,. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int 2011; 31 (Suppl 2): 61-80.
12. Kershenobich D, Razavi HA, Sanchez-Avila JF, et al,. Trends and projections of hepatitis C virus epidemiology in Latin America. Liver Int 2011; 31 (Suppl 2): 18-29.
13. Hatzakis A, Chulanov VP, Gadano AC,. The present and future disease burden of hepatitis C virus (HCV) with today's treatment paradigm-volume 2. J Viral Hepat 2015; 22 (Supp 1): 20-38.
14. United Nations. Department of Economic and Social Affairs. Population Division. World population prospects: The 2012 revision. 2014. Population database Available at: http://esa.un.org/unpd/wpp/index.htm (accessed 18 June 2014).
15. IMS Health. IMS Health MIDAS Data. IMS Health January 1, 2013. Available at: http://www.imshealth.com/portal/site/ims/menuitem.edb2b81823f67dab41d84b903208c22a/?vgnextoid=4475e3de7e390310VgnVCM1000007f8c2ca2RCRD (accessed 28 March 2014).
16. del Pino N, Oubina JR, Rodriguez-Frias F, et al,. Molecular epidemiology and putative origin of hepatitis C virus in random volunteers from Argentina. World J Gastroenterol 2013; 19: 5813-5827.
17. Personal Communication. Situaciõn epidemiolõgica en Argentina, 2014.
18. Instituto Nacional Central Único Coordinador de Ablaciõn e Implante. El Sistema Nacional de Informaciõn de Procuraciõn y Trasplante de la República Argentina. 2014 Available at: http://sintra.incucai.gov.ar/ (accessed 2 May 2014).
19. Personal Communication. Hospital Universitario Austral, Buenos Aires, Argentina. HCV clinic data. Center for Disease Analysis, Louisville, Colorado, USA, 2014.
20. Vladimirsky S, Silvina MM, Otegui L, et al,. [Surveillance of viral hepatitis in Argentina: analysis of information from sentinel units 2007-2010]. Acta Gastroenterol Latinoam 2013; 43: 22-30.
21. Cejas NG, Villamil FG, Lendoire JC, et al,. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy. Liver Transpl 2013; 19: 711-720.
22. Dalgard O, Jeansson S, Skaug K, Raknerud N, Bell H,. Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum. Scand J Gastroenterol 2003; 38: 864-870.
23. National Institute for Health and Welfare. [Infectious disease registry statistical database]. February 25, 2014. Available at: https://sampo.thl.fi/sampo-prod/cgi-bin/cognos.cgi?b-action=powerPlayService&ui.action=run&TARGET=%2Fcontent%2Ffolder%5B%40name%3D%27amor-prod%27%5D%2Ffolder%5B%40name%3D%27ttr%27%5D%2Fpackage%5B%40name%3D%27amor-ttr-shp-703-fi-prod%27%5D (accessed 12 June 2014).
24. Scandiatransplant. The Nordic Liver Transplant Registry. 2013. Available at: http://www.scandiatransplant.org/ (accessed 29 November 2013).
25. Papatheodoridis G, Sypsa V, Kantzanou M, Nikolakopoulos I, Hatzakis A,. Estimating the treatment cascade of chronic hepatitis B and C in Greece using a telephone survey. J Viral Hepat 2014 Sep 11. doi: 10.1111/jvh.12314. [Epub ahead of print].
26. Sypsa V, Touloumi G, Tassopoulos NC, et al,. Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection. J Viral Hepat 2004; 11: 366-374.
27. Katsoulidou A, Sypsa V, Tassopoulos NC, et al,. Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J Viral Hepat 2006; 13: 19-27.
28. Raptopoulou M, Touloumi G, Tzourmakliotis D, et al,. Significant epidemiological changes in chronic hepatitis C infection: results of the nationwide HEPNET-GREECE cohort study. Hippokratia 2011; 15: 26-31.
29. National Transplant Organization (EOM). Statistics. 2014. Available at: http://www.eom.gr/index.php?option=com-k2&view=item&layout=item&id=138&Itemid=142&lang=el (accessed 12 February 2014).
30. Chowdhury A, Santra A, Chaudhuri S, et al,. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology 2003; 37: 802-809.
31. Duseja A, Arora L, Masih B, et al,. Hepatitis B and C virus-prevalence and prevention in health care workers. Trop Gastroenterol 2002; 23: 125-126.
32. Kumar A, Sharma KA, Gupta RK, Kar P, Murthy NS,. Hepatitis C virus infection during pregnancy in North India. Int J Gynaecol Obstet 2005; 88: 55-56.
33. Kumar A, Sharma KA, Gupta RK, Kar P, Chakravarti A,. Prevalence & risk factors for hepatitis C virus among pregnant women. Indian J Med Res 2007; 126: 211-215.
34. Mahalakshmi B, Madhavan HN, Pushpalatha R, Margarita S,. Seroprevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among eye donors. Indian J Ophthalmol 2004; 52: 61-62.
35. Sharma A, Gur R, Bhalla P,. Study on prevalence of needle stick injury among health care workers in a tertiary care hospital in New Delhi: a two-year review. Indian J Public Health 2012; 56: 101-103.
36. Sood A, Sarin SK, Midha V, et al,. Prevalence of hepatitis C virus in a selected geographical area of northern India: a population based survey. Indian J Gastroenterol 2012; 31: 232-236.
37. Sukriti, Pati NT, Sethi A, et al,. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India. J Gastroenterol Hepatol 2008; 23: 1710-1715.
38. Thakral B, Marwaha N, Chawla YK, et al,. Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors. Indian J Med Res 2006; 124: 431-438.
39. Mittal G, Gupta P, Gupta R, Ahuja V, Mittal M, Dhar M,. Seroprevalence and risk factors of hepatitis B and hepatitis C virus infections in Uttarakhand, India. J Clin Exp Hepatol 2013; 3: 260-300.
40. Bagga PK, Singh SP,. Seroprevalence of hepatitis C antibodies in healthy blood donors-a prospective study. Indian J Pathol Microbiol 2007; 50: 429-432.
41. Ramani KV, Mavalankar D, Govil D,. Management of Blood Transfusion Services in India: An Illustrative Study of Maharashtra and Gujarat States. W P 2007. No. 2007-03-09. Available at: http://www.iimahd.ernet.in/publications/data/2007-03-09-kvramani.pdf (accessed 13 May 2014).
42. National AIDS Control Organization. Annual CMIS Bulletin 2008-09. 2009. Available at: http://naco.gov.in/upload/HIV%20data/NACO%20CMIS%20BULLETIN%202008-09.pdf (accessed 13 May 2014).
43. Kakodkar R, Soin A, Nundy S,. Liver transplantation in India: its evolution, problems and the way forward. Natl Med J India 2007; 20: 53-56.
44. Lubana PS,. Liver Transplantation: Present Scenario in India; Slide 17. 2014. Available at: http://www.slideshare.net/nicks1969/liver-transplantation-present-scenario-in-india # (18 March 2014).
45. Thornton L, Murphy N, Jones L, et al,. Determination of the burden of hepatitis C virus infection in Ireland. Epidemiol Infect 2011; 8: 1461-8.
46. Health Protection Surveillance Centre. HPSC Annual Reports, 2013.
47. Health Protection Surveillance Centre. National Hepatitis C Database for infection acquired through blood and blood products, 2010.
48. Houlihan D, Cooney A,. St. Vincent's University Hospital Dublin. Annual HCV-related transplants reported by Liver Transplant Unit, St. Vincent's University Hospital Dublin. Center for Disease Analysis, Louisville, CO, USA, 2014.
49. Zuckerman E,. Liver Unit, Carmel Medical Center, Haifa, Israel. Sources for the epidemiology of hepatitis C in Israel. Conversation with: Razavi HA. Center for Disease Analysis, Kromite, Louisville, CO, USA, August 2, 2010.
50. Ministry of Health Israel. Organ Transplants 2003-2013. 2014. Available at: http://www.health.gov.il/Subjects/Organ-transplant/transplant/Pages/default.aspx (accessed 4 March 2014).
51. Carmiel-Haggai M,. [Two decades of liver transplantation in Israel]. Harefuah 2012; 151: 679-683, 721.
52. Mossong J,. Hepatitis C in Luxembourg: a preliminary epideiological analysis of cases confirmed at the National Health Laboratory, 1990-2013, 2014.
53. Devaux C,. Report HCV CHL database Luxembourg, 2014.
54. Staub T,. Hepatitis C virus (HCV) genotype in Luxembourg. Conversation with: Razavi H, et al. Center for Disease Analysis, Louisville, CO, USA, January 23, 2014.
55. Eurotransplant. Statistics Report Library. 2013. Available at: http://statistics.eurotransplant.org/ (accessed 9 May 2013).
56. Eurotransplant. Eurotransplant Data Request-Belgium, 2013.
57. Valdespino JL, Conde-González CJ, Olaiz-Fernández G, Palma O, Kershenobich D, Sepúlveda J,. Seroprevalence of hepatitis C among Mexican adults: an emerging public health problem? Salud Pública Méx 2007; 49: s395-s403.
58. Burguete-Garcia AI, Conde-Gonzalez CJ, Jimenez-Mendez R, et al,. Hepatitis C seroprevalence and correlation between viral load and viral genotype among primary care clients in Mexico. Salud Publica Mex 2011; 53 (Suppl 1): S7-S12.
59. Jimenez-Mendez R, Uribe-Salas F, Lopez-Guillen P, Cisneros-Garza L, Castaneda-Hernandez G,. Distribution of HCV genotypes and HCV RNA viral load in different regions of Mexico. Ann Hepatol 2010; 9: 33-39.
60. Sanchez-Avila JF, Gonzalez E, Vazquez V, Suarez S, Uribe M,. Geographical distribution of HCV genotypes in Mexico. Ann Hepatol 2007; 6: 156-160.
61. Pan American Health Organization. Supply of Blood for Transfusion in the Caribbean and Latin American Countries 2006, 2007, 2008, and 2009. Washington, DC: Pan American Health Organization, 2010.
62. Organizaciõn Panamericana de la Salud. Medicina Transfusional en los Países del Caribe y Latinoamérica, 2000-2003. Washington, DC: Organizaciõn Panamericana de la Salud, 2005: 86.
63. Organizaciõn Panamericana de la Salud. Suministro de sangre para transfusiones en los países del Caribe y Latinoamérica en 2005: Datos basales para en plan regional de acciõn para seguridad transfusional 2006-2010 Pan American Health Organization (PAHO), 2007. Technical Documents. Access to Quality Products.
64. Pan American Health Organization. Supply of Blood for Transfusion in Latin American and Caribbean countries 2010 and 2011. Washington, DC: Pan American Health Organization, 2013.
65. Centro Nacional de Trasplantes. Estado Actual de Donaciõn y Trasplantes en México Anual 2013. Mexico: Centro Nacional de Trasplantes, 2014.
66. Hernandez-Dominguez JM, Holm-Corzo A, Santos-Caballero M, et al,. [Experience in liver transplantation (1996-2011) at the UMAE, General Hospital Gaudencio Gonzalez Garza, National Medical Center La Raza, Mexican Institute of Social Security, Mexico City, D.F]. Rev Invest Clin 2011; 63 (Suppl 1): 62-66.
67. Cisneros-Garza LE, Lopez-Hernandez PA, Munoz-Ramirez MR, et al,. [Liver transplant at the UMAE 25 IMSS Monterrey]. Rev Invest Clin 2011; 63 (Suppl 1): 67-72.
68. Perez-Rodriguez E, Munoz-Espinosa LE, Zapata-Chavira H, et al,. [Orthotopic liver transplantation. Experience in the University Hospital of Monterrey, N.L]. Rev Invest Clin 2011; 63 (Suppl 1): 79-84.
69. Rodriguez-Montalvo C, Tijerina-Gomez L, Flores-Villalba E, et al,. [Twelve years of liver transplant at the San Jose-Tec De Monterrey Hospital]. Rev Invest Clin 2011; 63 (Suppl 1): 73-78.
70. Baatarkhuu O, Kim DY, Ahn SH, et al,. Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population-based nationwide study. Liver Int 2008; 28: 1389-1395.
71. Tserenpuntsag B, Ouynbileg L, Nelson K, McNutt LA,. Prevalence of infectious diseases among Mongolian blood donors. J Infect Dev Ctries 2008; 2: 73-75.
72. Vriend HJ, Van Veen MG, Prins M, Urbanus AT, Boot HJ, Op De Coul EL,. Hepatitis C virus prevalence in The Netherlands: migrants account for most infections. Epidemiol Infect 2013; 141: 1310-1317.
73. Micallef JM, Kaldor JM, Dore GJ,. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 2006; 13: 34-41.
74. Vriend HJ, Op de Coul EL, van de Laar TJ, Urbanus AT, van der Klis FR,. et al. Hepatitis C seroprevalence in the Netherlands. Eur J Public Health 2012; 22: 819-21.
75. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ,. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705-714.
76. de Vries MJ, te Rijdt B, van Nieuwkerk CM,. Genotype distribution amongst hepatitis C patients in The Netherlands. Neth J Med 2006; 64: 109-113.
77. GIPdatabank. Aantal gebruikers 2009-2013 voor ATC-subgroep J05AB04: Ribavirine. March 7, 2014. Available at: https://www.gipdatabank.nl/databank.asp (accessed 16 July 2014).
78. Eurotransplant. Eurotransplant Statistics-2013. January 8, 2014. Available at: https://www.eurotransplant.org/cms/mediaobject.php?file=year-20131.pdf (accessed 27 November 2013).
79. van Peter Jansen A,. Doen we voldoende levertransplantaties in Nederland? 2013. Available at: http://www.mdl.nl/p-vragen?func=viewSubmission&wid=67&sid=38 (accessed 18 November 2013).
80. The Hepatitis Foundation of New Zealand. Hepatitis C. January 1, 2013. Available at: http://www.hepatitisfoundation.org.nz/index.php/hepc/ (accessed 17 February 2014).
81. Brunton C,. Canterbury District Health Board, Christchurch, New Zealand. HCV clinic data. Center for Disease Analysis, Louisville, CO, USA, 2014.
82. Gane E,. Hepatitis C virus (HCV) genotype in New Zealand. Center for Disease Analysis, Louisville, CO, USA, February 20, 2014.
83. Australia. Dept. of Health and Aging. Third National Hepatitis C Strategy 2010-2013. Commonwealth of Australia, 2010. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/8377190373B0053DCA257BF0001CBE98/#x0024;File/hcv.pdf (accessed 5 November 2013)
84. The Kirby Institute for Infection and Immunity in Society. HIV, viral hepatitis and sexually transmissible infections in Australia. Annual Surveillance Reports 1997-2013. November 21, 2013. Available at: http://www.kirby.unsw.edu.au/surveillance/Annual-Surveillance-Reports (accessed 21 November 2013).
85. Australia & New Zealand Organ Donation Registry. Annual reports (1997-2012). November 21, 2013. Available at: http://www.anzdata.org.au/anzod/v1/reports.html (accessed November 21, 2013).
86. Norwegian Surveillance System for Communicable Diseases (MSIS). 2014. Available at: http://www.msis.no/ (accessed 5 June 2014).
87. The Norwegian Institute for Public Health. Norwegian Prescription Database-Ribavirin. 2014. Available at: http://www.norpd.no (accessed 5 June 2014).
88. Scandiatransplant. Historical data: Transplantation figures. 2013 (accessed November 2013).
89. Scholz T, Karlsen TH, Sanengen T, et al,. [Liver transplantation in Norway through 25 years]. Tidsskr Nor Laegeforen 2009; 129: 2587-2592.
90. El-Serag HB,. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142: 1264-1273.
91. Flisiak R, Halota W, Horban A, Juszczyk J, Pawlowska M, Simon K,. Prevalence and risk factors of HCV infection in Poland. Eur J Gastroenterol Hepatol 2011; 23: 1213-1217.
92. Godzik P, Kolakowska A, Madalinski K, et al,. [Prevalence of anti-HCV antibodies among adults in Poland-results of cross-sectional study in general population]. Przegl Epidemiol 2012; 66: 575-580.
93. Bielawski K, Wlasiuk M, Truskolawska M, Falkiewicz B,. HCV infection in Poland. Arch Med Res 2000; 31: 532-535.
94. Kryczka W, Zarebska-Michaluk D, Chrapek M,. [The impact of coexisting diseases on the course of chronic hepatitis C]. Przegl Epidemiol 2005; 59: 405-410.
95. Braczkowska B, Kowalskan M, Zejda JE, et al,. Prevalence and basic determinants of hepatitis C antibodies in medical students in Katowice, Poland. Przegl Lek 2006; 63: 539-542.
96. Borzecka B, Bludzin W,. [The program of early detection of HCV infection]. Przegl Epidemiol 2007; 61: 733-738.
97. Ganczak M, Szych Z,. Rationale against preoperative screening for HIV in Polish hospitals: a prevalence study of anti-HIV in contrast to anti-hepatitis C virus and hepatitis B surface antigen. Infect Control Hosp Epidemiol 2009; 30: 1227-1229.
98. Aniszewska M, Kowalik-Mikolajewska B, Pokorska-Lis M, Kalinowska M, Cianciara J, Marczyrnska M,. [Seroprevalence of anti-HCV in pregnant women. Risk factors of HCV infection]. Przegl Epidemiol 2009; 63: 293-298.
99. Zagozdzon P, Parszuto J, Raj A, Calus-Kania D, Korczak A, Ejsmont J,. [Prevalence and risk factors of chronic hepatitis C virus infection among health-care workers in Pomeranian voivodeship]. Przegl Epidemiol 2009; 63: 39-43.
100. Ganczak M, Szych Z,. [Rationale for the implementation of pre-operative testing for HCV in the light of anti-HCV and HBsAG tests results in surgical patients from a teaching hospital]. Przegl Epidemiol 2009; 63: 387-392.
101. Czerwinski J, Malanowski P, Wasiak D, et al,. Viral hepatitis B and C markers in the population of deceased donors in Poland. Transplant Proc 2007; 39: 2695-2697.
102. National Institute of Public Health-National Institute of Hygiene (NIPH-NIH). [Infectious Diseases and Poisonings in Poland in 2012]. Warsaw, Poland: National Institute of Public Health, National Institute of Hygiene, 2013.
103. Poltransplant. Organ Transplantation Statistics-2013. Warsaw, Poland: Centrum Organizacyjno-Koordynacyjne Do Spraw Transplantacji, 2013.
104. Krawczyk M, Grat M, Barski K, et al,. 1000 liver transplantations at the Department of General, Transplant and Liver Surgery, Medical University of Warsaw-analysis of indications and results. Pol Przegl Chir 2012; 84: 304-312.
105. Viral Hepatitis Prevention Board. Country Sessions: Russia. Viral Hepatitis 2011; 19: 33.
106. Pimenov NN, Vdovin AV, Komarova SV, Mamonova NA, Chulanov VP, Pokrovskii VI,. [The relevance and prospects of introducing a uniform federal register of patients with viral hepatitis B and C in Russia]. Ter Arkh 2013; 85: 4-9.
107. Iashina TL, Favorov MO, Shakhgil'dian IV, et al,. [The spread of hepatitis C markers among the population of regions of Russia and Central Asia]. Zh Mikrobiol Epidemiol Immunobiol 1993; (5): 46-49.
108. Pimenov NN, Chulanov VP, Komarova SV, et al,. [Hepatitis C in Russia: current epidemiology and approaches to improving diagnosis and surveillance]. Epidemiol Infect Dis 2012; 4: 4-10.
109. Yuschuk ND, Znoyko OO, Yakushechkina NA, et al,. [Assessment of the socio-economic burden of hepatitis C in the Russian Federation]. Epidemiol Vaccine Prevent 2013; 2: 18-33.
110. Gautier SV, Moysyuk YG, Khomyakov SM, Ibragimova OS,. [Organ donation and transplantation in Russian Federation in 2011: 4th report of National Registry]. Bull Transplant Artificial Organs 2012; 3: 6-18.
111. Gautier SV, Moysyuk YG, Khomyakov SM, Ibragimova OS,. [Progress in organ donation and transplantation in Russian Federation in 2006-2010: 3th report of National Registry]. Bull Transplant Artificial Organs 2011; 2: 6-20.
112. Granov AM, Granov DA, Zherebtsov FK, et al,. [An experience with 100 cadaveric transplantations of the liver in the Russian Research Center of Radiology and Surgical Technologies]. Bull Transplant Artificial Organs 2012; 2: 11-16.
113. Andreytseva OI, Kozlova AV, Sutkin VE,. [Liver transplantation and HBV infection]. Bull Transplant Artificial Organs 2009; 4: 110-117.
114. Schreter I, Kristian P, Klement C, et al,. [Prevalence of hepatitis C virus infection in Slovakia]. Klin Mikrobiol Infekc Lek 2007; 13: 54-58.
115. Public Health Authority of the Slovak Republic. Epidemiological Information System. 2014. Available at: http://www.epis.sk/InformacnaCast/Publikacie/VyrocneSpravy.aspx (accessed 19 June 2014).
116. IRODaT. International Registry on Organ Donation and Transplantation. July 9, 2014. Available at: http://www.irodat.org/?p=database&c=SK#data (accessed 1 March 2014).
117. Adam R, Karam V, Delvart V, et al,. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol 2012; 57: 675-688.
118. Prabdial-Sing N, Puren A, Schoub B,. The status of hepatitis c-the slient "volcano"-in South Africa. National Institute or Communicable Diseaess, April 2013. Report No.: 11(1).
119. Parboosing R, Paruk I, Lalloo UG,. Hepatitis C virus seropositivity in a South African Cohort of HIV co-infected, ARV naive patients is associated with renal insufficiency and increased mortality. J Med Virol 2008; 80: 1530-1536.
120. Organ Donor Foundation. Transplant Statistics. 2014. Available at: http://www.odf.org.za/2013-06-11-09-17-45/statistics.html (accessed 10 April 2014).
121. Esteban JI, Sauleda S, Quer J,. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 2008; 48: 148-162.